Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 398 | 201 | 0 |
| Operating Income | -398 | -201 | N/A |
| Other Income | -3,627 | 6,520 | 0 |
| Pre-tax Income | -4,025 | 6,319 | 0 |
| Net Income Continuous | -4,025 | 6,319 | N/A |
| Net Income | $-4,025 | $6,319 | $N/A |
| EPS Basic Total Ops | -8.63 | 20.86 | N/A |
| EPS Basic Continuous Ops | -41.97 | 65.89 | N/A |
| EPS Diluted Total Ops | -8.63 | 20.86 | N/A |
| EPS Diluted Continuous Ops | -41.97 | 65.89 | N/A |
| EBITDA(a) | $-398 | $-201 | $N/A |